Literature DB >> 30904888

Unusual first presentation of a metabolic disorder.

Claire Emma Strauss1, Gayle Hann2.   

Abstract

An 8-month-old boy presented to hospital with a fever, irritability and 'back arching'. On examination, he demonstrated profound opisthotonic posturing and had tonsillitis. He had a full septic screen and was treated with broad spectrum antibiotics. Blood tests showed a transaminitis, raised alpha fetoprotein and deranged clotting. The clotting abnormalities and raised alpha fetoprotein persisted post discharge and an abdominal ultrasound showed steatosis, splenomegaly and bilateral increased renal cortical reflectivity. A full metabolic screen revealed type 1 tyrosinaemia. The opisthotonic posturing, a major part of this child's presentation, has not been reported as a presenting feature of tyrosinaemia. It was part of a 'neurological crisis' caused by tyrosinaemia and exacerbated by the intercurrent infection. These are known to occur in tyrosinaemia but not commonly as the first presentation. This represents an unusual presentation of a metabolic condition which, without intervention, can lead to severe hepatic, renal and neurodevelopmental complications. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  congenital disorders; metabolic disorders; paediatrics

Mesh:

Substances:

Year:  2019        PMID: 30904888      PMCID: PMC6510225          DOI: 10.1136/bcr-2018-226716

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  19 in total

1.  An infant with prolonged circumcision bleeding and unexplained coagulopathy.

Authors:  Ali Bay; Ozlem Karaoglu; Ercan Sivasli; Göksel Leblebisatan; Mehmet Keskin
Journal:  Indian J Hematol Blood Transfus       Date:  2011-09-21       Impact factor: 0.900

2.  Phenylalanine supplementation improves the phenylalanine profile in tyrosinaemia.

Authors:  C J Wilson; K G Van Wyk; J V Leonard; P T Clayton
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

3.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

4.  Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability.

Authors:  R Jorquera; R M Tanguay
Journal:  Hum Mol Genet       Date:  2001-08-15       Impact factor: 6.150

5.  Nitisinone in the treatment of hereditary tyrosinaemia type 1.

Authors:  Patrick J McKiernan
Journal:  Drugs       Date:  2006       Impact factor: 9.546

6.  The mutagenicity of the tyrosine metabolite, fumarylacetoacetate, is enhanced by glutathione depletion.

Authors:  R Jorquera; R M Tanguay
Journal:  Biochem Biophys Res Commun       Date:  1997-03-06       Impact factor: 3.575

Review 7.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Authors:  E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

8.  Tyrosinemia type 1 and irreversible neurologic crisis after one month discontinuation of nitisone.

Authors:  Neslihan Önenli Mungan; Dinçer Yıldızdaş; Deniz Kör; Özden Özgür Horoz; Faruk İncecik; Murat Öktem; Johannes Sander
Journal:  Metab Brain Dis       Date:  2016-05-17       Impact factor: 3.584

9.  Long-term cognitive functioning in individuals with tyrosinemia type 1 treated with nitisinone and protein-restricted diet.

Authors:  María Ignacia García; Alicia de la Parra; Carolina Arias; Miguel Arredondo; Juan Francisco Cabello
Journal:  Mol Genet Metab Rep       Date:  2017-03-26

Review 10.  Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations.

Authors:  Jeffrey M Chinsky; Rani Singh; Can Ficicioglu; Clara D M van Karnebeek; Markus Grompe; Grant Mitchell; Susan E Waisbren; Muge Gucsavas-Calikoglu; Melissa P Wasserstein; Katie Coakley; C Ronald Scott
Journal:  Genet Med       Date:  2017-08-03       Impact factor: 8.822

View more
  1 in total

1.  Hereditary Tyrosinemia Compounded With Hyperinsulinemic Hypoglycemia: Challenging Diagnosis of a Rare Case.

Authors:  Sharmeen Nasir; Mohammad Raza; Samrah I Siddiqui; Ayesha Saleem; Awais Abbas
Journal:  Cureus       Date:  2020-11-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.